MDxHealth suspends FY2026 revenue guidance of $110M-$115M; reports preliminary Q3 revenue of ~$22.7M

MDxHealth suspended its FY2026 revenue guidance of $110M-$115M and reported preliminary Q3 revenue of about $22.7 million, flat versus $22.7 million a year ago.

Detected & updated continuously · Source: Nebula